Juan Lei

997 total citations
32 papers, 685 citations indexed

About

Juan Lei is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Juan Lei has authored 32 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Juan Lei's work include Immune cells in cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Juan Lei is often cited by papers focused on Immune cells in cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Juan Lei collaborates with scholars based in China, Montenegro and United States. Juan Lei's co-authors include Yongsheng Li, Yu Zhou, Lei Wu, Jiangang Zhang, Huakan Zhao, Guifang Yan, Jingchun Wang, Lu Zheng, Hongming Miao and Qi Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Science Advances.

In The Last Decade

Juan Lei

27 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juan Lei China	13	320	244	213	122	99	32	685
Germana Cicciarelli Italy	8	288 0.9×	175 0.7×	228 1.1×	132 1.1×	58 0.6×	9	639
Jones Gyamfi Ghana	7	345 1.1×	176 0.7×	258 1.2×	260 2.1×	81 0.8×	11	734
Huaxin Zhou China	16	397 1.2×	166 0.7×	151 0.7×	150 1.2×	104 1.1×	42	756
Zhao Tang China	14	269 0.8×	96 0.4×	155 0.7×	122 1.0×	94 0.9×	37	626
Yiting Tang China	17	637 2.0×	120 0.5×	301 1.4×	105 0.9×	82 0.8×	31	965
Zhan Zhang China	12	331 1.0×	190 0.8×	149 0.7×	370 3.0×	77 0.8×	21	863
Donghai Xiong United States	19	495 1.5×	193 0.8×	216 1.0×	290 2.4×	138 1.4×	39	987
Xiaolong Ma China	17	388 1.2×	96 0.4×	136 0.6×	99 0.8×	105 1.1×	28	621
Dongxian Guan China	14	503 1.6×	154 0.6×	250 1.2×	255 2.1×	67 0.7×	17	891

Countries citing papers authored by Juan Lei

Since Specialization

Citations

This map shows the geographic impact of Juan Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Lei more than expected).

Fields of papers citing papers by Juan Lei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Lei. The network helps show where Juan Lei may publish in the future.

Co-authorship network of co-authors of Juan Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Lei. A scholar is included among the top collaborators of Juan Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Lei. Juan Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yu, Nan Zhang, Danyang Li, et al.. (2025). Macrophage CCL7 promotes resistance to immunotherapy for colorectal cancer by regulating the infiltration of macrophages and CD8 ⁺ T cells. Journal for ImmunoTherapy of Cancer. 13(11). e013027–e013027.

Gong, Li, Juan Lei, Yu Zhou, et al.. (2025). Regulation of Histone Acetylation During Inflammation Resolution. ImmunoTargets and Therapy. Volume 14. 1145–1158.

Chen, Yu, Juan He, Luyao Shen, et al.. (2025). Cholesterol 25‐Hydroxylase Enhances Myeloid‐Derived Suppressor Cell (MDSC) Immunosuppression via the Stimulator of Interferon Genes (STING)‐Tank‐Binding Kinase 1 (TBK1)‐Receptor‐Interacting Protein Kinase 3 (RIPK3) Pathway in Colorectal Cancer. MedComm. 6(10). e70411–e70411.

Yuan, Ye, Shixue Yang, Lihong Wang, et al.. (2025). Endothelial cell-derived SDF-1α elicits stemness traits of glioblastoma via dual-regulation of GLI1. Theranostics. 15(18). 9819–9837.

Zhang, Jiangang, Juan Lei, Xudong Liu, et al.. (2024). LC-MS simultaneous profiling of acyl-CoA and acyl-carnitine in dynamic metabolic status. Analytica Chimica Acta. 1329. 343235–343235. 3 indexed citations

Lei, Juan, Lei Wu, Nan Zhang, et al.. (2024). Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis. Molecular Biomedicine. 5(1). 19–19. 5 indexed citations

Chen, Yu, Yanquan Xu, Huakan Zhao, et al.. (2023). Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion. Cancer Letters. 564. 216208–216208. 15 indexed citations

Zhang, Jiangang, Yu Zhou, Juan Lei, et al.. (2023). Retention time prediction and MRM validation reinforce the biomarker identification of LC-MS based phospholipidomics. The Analyst. 149(2). 515–527. 2 indexed citations

Yang, Shuai, Guifang Yan, Juan Lei, et al.. (2023). Increased OIT3 in macrophages promotes PD-L1 expression and hepatocellular carcinogenesis via NF-κB signaling. Experimental Cell Research. 428(2). 113651–113651. 5 indexed citations

10.

Wu, Lei, Juan Lei, Nan Zhang, et al.. (2023). Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells. Journal for ImmunoTherapy of Cancer. 11(12). e008081–e008081. 12 indexed citations

11.

Yang, Shuai, Jiangang Zhang, Yanquan Xu, et al.. (2022). OIT3 mediates macrophage polarization and facilitates hepatocellular carcinoma progression. Cancer Immunology Immunotherapy. 71(11). 2677–2689. 11 indexed citations

12.

Yang, Shuai, Jiangang Zhang, Jingchun Wang, et al.. (2022). Nomogram for Prediction of Hepatocellular Carcinoma Prognosis. Current Bioinformatics. 17(8). 685–697. 1 indexed citations

13.

Jiang, Mingzhu, Min Zhao, Mi Bai, et al.. (2021). SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation. SHILAP Revista de lepidopterología. 7(4). 293–305. 14 indexed citations

14.

Zhang, Jian Gang, Shuai Yang, Jingchun Wang, et al.. (2021). Integrated LC-MS metabolomics with dual derivatization for quantification of FFAs in fecal samples of hepatocellular carcinoma patients. Journal of Lipid Research. 62. 100143–100143. 11 indexed citations

15.

Zhang, Cailiang, Qibing Zeng, Yalan Liu, et al.. (2021). Family History of Hypertension and Cobalt Exposure Synergistically Promote the Prevalence of Hypertension. Biological Trace Element Research. 200(3). 943–952. 3 indexed citations

16.

Wu, Lei, Xiao Zhang, Lu Zheng, et al.. (2020). RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis. Cancer Immunology Research. 8(5). 710–721. 200 indexed citations

17.

Zhang, Xiao, Lei Wu, Yanquan Xu, et al.. (2020). Microbiota-derived SSL6 enhances the sensitivity of hepatocellular carcinoma to sorafenib by down-regulating glycolysis. Cancer Letters. 481. 32–44. 22 indexed citations

18.

Zhao, Huakan, Guifang Yan, Lu Zheng, et al.. (2020). STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma. Theranostics. 10(14). 6483–6499. 64 indexed citations

19.

Zhang, Qi, Guifang Yan, Juan Lei, et al.. (2020). The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer. Molecular Medicine. 26(1). 39–39. 27 indexed citations

20.

Yan, Guifang, Huakan Zhao, Qi Zhang, et al.. (2018). A RIPK3-PGE2 Circuit Mediates Myeloid-Derived Suppressor Cell–Potentiated Colorectal Carcinogenesis. Cancer Research. 78(19). 5586–5599. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact